Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
This drug is a dual GLP-1RA and glucose-dependent insulinotropic peptide (GIP) agonist, which means it also functions like GIP to increase insulin secretion and slow gastric emptying
Dosage and duration of use have not been established
Important Facts in GLP-1 Domain 5.3
Clinical Scenarios: What IGFBP-3 Reveals IGFBP-3, Cancer Risk, and Longevity One of the most compelling reasons to measure IGFBP-3 is its inverse relationship with cancer risk: Studies show that low IGFBP-3 paired with high IGF-1 is associated with increased risk of: Prostate cancer Breast cancer Colorectal cancer Why
The thigh absorbs GLP-1 medications slightly slower, producing a gentler onset of effects
This precision matters because contaminated or improperly formulated medications can increase gastrointestinal side effects
US$ 22.98
US$ 28.37
US$ 25.25
US$ 28.84
US$ 22.75
US$ 29.80
US$ 20.60
US$ 26.63
US$ 26.56
US$ 24.03
US$ 24.51
US$ 20.23
US$ 26.52
